InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
6
T+90 hit rate
33%
T+90 mean return
+2.6%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by WINSTON ROY, Executive. Insider active across 1 company, notably Pacira BioSciences, Inc.. Aggregated, 13 disclosures have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €457k. Activity tracked since 4 June 2021. The latest transaction was filed on 2 August 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations13 total
509 shares@ US$34.8751.3% of flowCommon StockSEC:0001396814-23-000041:0
10,950 shares0Common StockSEC:0001209191-23-038033:0
1,779 shares@ US$38.9915.0% of flowCommon StockSEC:0001209191-23-035266:0
476 shares@ US$55.702.0% of flowCommon StockSEC:0001209191-22-044560:0
2,099 shares@ US$61.3740.011% mcap10.2% of flowCommon StockSEC:0001209191-22-035234:0
10,000 shares@ US$48.150.039% mcap35.2% of flowCommon StockSEC:0001209191-21-063386:0
10,000 shares@ US$48.1532.2% of flowCommon StockSEC:0001209191-21-063386
5,000 shares0Common StockSEC:0001209191-21-049945:0
5,000 shares0Common StockSEC:0001209191-21-049945
7,000 shares0Common StockSEC:0001209191-21-040089
7,000 shares0Common StockSEC:0001209191-21-040089:0
2,276 shares@ US$61.0370.011% mcap9.7% of flowCommon StockSEC:0001209191-21-038903:0
2,276 shares@ US$61.0378.9% of flowCommon StockSEC:0001209191-21-038903
13 of 13 declarations
About WINSTON ROY
Roy Winston is the Chief Clinical Officer and Chief Medical Officer of Pacira BioSciences, Inc. He oversees the clinical and medical operations of the company, which specializes in pain management solutions. His medical expertise is essential for Pacira's innovation.
